Thrombospondin 1 mediates angiotensin II induction of TGF-β activation by cardiac and renal cells under both high and low glucose conditions

Biochemical and Biophysical Research Communications

Volumn 339, Issue 2, 2006, Pages 633-641

  Zhou, Yong ^a   Poczatek, Maria H ^a   Berecek, Kathleen H ^b   Murphy Ullrich, Joanne E ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Angiotensin; Diabetes; Fibrosis; Growth factors; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; GLUCOSE; GROWTH FACTOR; LOSARTAN; PEPTIDE ANTIBODY; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HYPERTENSION; KIDNEY CELL; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; GLUCOSE; HEART; KIDNEY; MYOCYTES, CARDIAC; RATS; SOLUBILITY; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA;

EID: 28444464515     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.060     Document Type: Article

References (33)

1. K.T. Weber Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation Circulation 96 1997 4065 4082
2. J. Hou, H. Kato, R.A. Cohen, A.V. Chobanian, and P. Brecher Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase J. Clin. Invest. 96 1995 2469 2477
3. S.M. Factor, R. Bhan, T. Minase, H. Wolinsky, and E.H. Sonnenblick Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease Am. J. Pathol. 102 1981 219 228
4. F.S. Fein, J.M. Capasso, R.S. Aronson, S. Cho, C. Nordin, B. Miller-Green, E.H. Sonnenblick, and S.M. Factor Combined renovascular hypertension and diabetes in rats: a new preparation of congestive cardiomyopathy Circulation 70 1984 318 330
5. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N. Engl. J. Med. 329 1993 1456 1462
6. B. Schieffer, A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U.N. Riede, and H. Drexler Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat Circulation 89 1994 2273 2282
7. S. Kim, and H. Iwao Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol. Rev. 52 2000 11 34
8. T. Yamamoto, T. Nakamura, N.A. Noble, E. Ruoslahti, and W.A. Border Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy Proc. Natl. Acad. Sci. USA 90 1993 1814 1818
9. Y. Isaka, Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney J. Clin. Invest. 92 1993 2597 2601
10. K. Sharma, Y. Jin, J. Guo, and F.N. Ziyadeh Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 1996 522 530
11. T. Naito, T. Masaki, D.J. Nikolic-Paterson, C. Tanji, N. Yorioka, and N. Kohno Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1 Am. J. Physiol. Renal. Physiol. 286 2004 F278 F287
12. C. Weigert, K. Brodbeck, K. Klopfer, H.U. Haring, and E.D. Schleicher Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia Diabetologia 45 2002 890 898
13. J.E. Murphy-Ullrich, and M. Poczatek Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology Cytokine Growth Factor Rev. 11 2000 59 69
14. S. Schultz-Cherry, and J.E. Murphy-Ullrich Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism J. Cell Biol. 122 1993 923 932
15. S. Schultz-Cherry, H. Chen, D.F. Mosher, T.M. Misenheimer, H.C. Krutzsch, D.D. Roberts, and J.E. Murphy-Ullrich Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1 J. Biol. Chem. 270 1995 7304 7310
16. S.E. Crawford, V. Stellmach, J.E. Murphy-Ullrich, S.M. Ribeiro, J. Lawler, R.O. Hynes, G.P. Boivin, and N. Bouck Thrombospondin-1 is a major activator of TGF-beta1 in vivo Cell 93 1998 1159 1170
17. M.H. Poczatek, C. Hugo, V. Darley-Usmar, and J.E. Murphy-Ullrich Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1 Am. J. Pathol. 157 2000 1353 1363
18. N. Yevdokimova, N.A. Wahab, and R.M. Mason Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose J. Am. Soc. Nephrol. 12 2001 703 712
19. F.J. Villarreal, N.N. Kim, G.D. Ungab, M.P. Printz, and W.H. Dillmann Identification of functional angiotensin II receptors on rat cardiac fibroblasts Circulation 88 1993 2849 2861
20. M. Abe, J.G. Harpel, C.N. Metz, I. Nunes, D.J. Loskutoff, and D.B. Rifkin An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct Anal. Biochem. 216 1994 276 284
21. C.C. Chua, R.C. Hamdy, and B.H. Chua Regulation of thrombospondin-1 production by angiotensin II in rat heart endothelial cells Biochim. Biophys. Acta 1357 1997 209 214
22. J.W. Fischer, M. Stoll, A.W. Hahn, and T. Unger Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells Cardiovasc. Res. 51 2001 784 791
23. L.A. Sechi, C.A. Griffin, and M. Schambelan The cardiac renin-angiotensin system in STZ-induced diabetes Diabetes 43 1994 1180 1184
24. P.J. Sime, Z. Xing, F.L. Graham, K.G. Csaky, and J. Gauldie Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung J. Clin. Invest. 100 1997 768 776
25. M. Bayraktar, S. Dundar, S. Kirazli, and F. Teletar Platelet factor, 4 beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients J. Int. Med. Res. 22 1994 90 94
26. B. McGregor, S. Colon, M. Mutin, E. Chignier, P. Zech, and J. McGregor Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis Am. J. Pathol. 144 1994 1281 1287
27. G.J. Raugi, and D.H. Lovett Thrombospondin secretion by cultured human glomerular mesangial cells Am. J. Pathol. 129 1987 364 372
28. V.Y. Wong, N.J. Laping, L.C. Contino, B.A. Olson, E. Grygielko, and D.P. Brooks Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan Physiol. Genomics 4 2000 35 42
29. S. Kagami, T. Kuhara, K. Okada, Y. Kuroda, W.A. Border, and N.A. Noble Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells Kidney Int. 51 1997 664 671
30. J.S. Munger, X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, D.B. Rifkin, and D. Sheppard The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis Cell 96 1999 319 328
31. D. Mu, S. Cambier, L. Fjellbirkeland, J.L. Baron, J.S. Munger, H. Kawakatsu, D. Sheppard, V.C. Broaddus, and S.L. Nishimura The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1 J. Cell Biol. 157 2002 493 507
32. S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, and S.L. Nishimura Integrin {alpha}v{beta}8-mediated activation of transforming growth factor-{beta} by perivascular astrocytes: an angiogenic control switch Am. J. Pathol. 166 2005 1883 1894
33. S.W. Rabkin The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte Can. J. Physiol. Pharmacol. 74 1996 125 131